PATENT CLAIM ANALYSIS

Application Number: 16085536
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-07
Patent Classification: ["514", "259300"]

Abstract:
Provided are isotopologues of isoquinolinone and quinazolinone compounds of formula (AB′) that modulate PI3 kinase activity, processes for the preparation of the compounds, pharmaceutical compositions comprising the compounds, and methods of treatment of diseases and disorders using the compounds or pharmaceutical compositions.

Claim (Index 40):
The compound of  claim 1 , wherein R is C 1 -C 3  alkyl optionally substituted with one or more deuterium.

Metadata:
- Claim Count in Document: 98.0
- Percentile: 97.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14874328', '15621815', '15755475', '14695699', '15794816']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6972665979499107
- 35 USC 102 Novelty (BERT): 0.5162795255032657
- Combined Prediction Score: 0.6791678907052463
- Mean Citation Score: 265.08322000000004
- Max Citation Score: 268.01678
- Similarity Product: 185.7895972261084

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test